Menu

Skip to content
  • Home
  • About Us
  • Services
  • Products
  • Contact Us
  • News & Events

In development

Patented products available for R&D use as permitted under 35 USC 271 (e)(1)
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A
Afatinib
Ansamitocin P-3
Axitinib
B
Besifloxacin
Brexpiprazole
Brivaracetam
D
Dalbavancin
Dapagliflozin
Degarelix acetate
E
Emodepside
Empagliflozin
Epothilone B
Eribulin Mesilate
Everolimus
F
Ferric Carboxymaltose
Fulvestrant
I
Iodixanol
Ivacaftor
Ixazomib
L
Lenalidomide
Lurasidone HCl
M
Memantine HCl
Midostaurin
Migalastat
N
Naquotinib
Neratinib
Niraparib
O
Oritavancin
P
Palbociclib
Paliperidone Palmitate
Parnaparin Sodium
Platensimycin
Pomalidomide
Q
Quinupristin
R
Radezolid
Ravuconazole
Regorafenib
Retigabine
Robenacoxib
Rucaparib
S
Simeprevir
Sofosbuvir
T
Tasimelteon
Tedizolid
Terlipressin acetate
Trabectedin
Tulathromycin
Tylosin
U
Upadacitinib
V
Valrubicin
Vilazodone HCl